Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Cytiva rProtein A Sepharose™ Fast Flow Affinity Media

Designed for purification of monoclonal and polyclonal antibodies at labs and process scales

Supplier:  Cytiva 17127903

Request Bulk Order

 View more versions of this product

Catalog No. 45-002-973


Add to Cart

Description

Description

  • Composed of recombinant protein A coupled with cross-linked 4% agarose base matrix
  • High dynamic binding capacity, single-point attachment of protein A, with high recovery, high purity and low ligand leakage
  • No mammalian components involved during manufacturing process
  • Matrix: 4% cross-linked agarose
  • Average particle size: 90μm (d50V)
  • Ligand: 6mg rProtein A/mL medium (E. coli)
  • Binding capacity: ∽50mg human IgG/mL media
  • pH stability working range: 3 to 10
  • Pressure/Flow specification: base matrix 150 to 250cm/hr., 100kPa, XK 50/60 column, bed
Specifications

Specifications

200 mL
Stable in aqueous Buffers commonly used in Protein A Chromatography
50 mg Human lgG/mL medium2
150 to 250 cm/Hoμr
9.84 in.
100 kPa
2 to 9
Recombinant Protein A (E. coli)
For PurifiCatIon of Monoclonal and Polyclonal Antibodies at Labs and Process Scales
2°C to 8°C
rProtein A Sepharose Fast Flow Media
60 to 165 μm
25 cm
4% Cross-Linked Agarose
20% Ethanol
Product Suggestions

Product Suggestions

SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Provide Content Correction

We continue to work to improve your shopping experience and your feedback regarding this content is very important to us. Please use the form below to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Cancel Submit